Novel motif:118: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif118_AATCCGGCT
|novel_motifs_human_sample_pval=11376-118A8_11051;0.14258,11327-117E4_11969;0.42887,11473-119C6_11054;0.0540357,11474-119C7_12067;0.68...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:10, 9 September 2013
name: | motif118_AATCCGGCT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0031167 | rRNA methylation | 1.880964e-8 |
GO:0009744 | response to sucrose stimulus | 8.964676e-8 |
GO:0010871 | negative regulation of receptor biosynthetic process | 2.944896e-7 |
GO:0000154 | rRNA modification | 3.165911e-7 |
GO:0043457 | regulation of cellular respiration | 4.277974e-7 |
GO:0006391 | transcription initiation from mitochondrial promoter | 4.523933e-7 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 5.647065e-7 |
GO:0009589 | detection of UV | 5.647065e-7 |
GO:0015742 | alpha-ketoglutarate transport | 6.789946e-7 |
GO:0070489 | T cell aggregation | 8.424625e-7 |
GO:0006290 | pyrimidine dimer repair | 1.488336e-6 |
GO:0042137 | sequestering of neurotransmitter | 1.776669e-6 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 2.922363e-6 |
GO:0046732 | active induction of host immune response by virus | 3.689583e-6 |
GO:0002456 | T cell mediated immunity | 3.956429e-6 |
GO:0051383 | kinetochore organization | 4.309302e-6 |
GO:0051382 | kinetochore assembly | 5.495637e-6 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 5.827152e-6 |
GO:0006261 | DNA-dependent DNA replication | 6.694707e-6 |
GO:0055099 | response to high density lipoprotein particle stimulus | 7.271615e-6 |
GO:0000088 | mitotic prophase | 9.953653e-6 |
GO:0060364 | frontal suture morphogenesis | 1.246552e-5 |
GO:0050765 | negative regulation of phagocytosis | 1.868442e-5 |
GO:0021557 | oculomotor nerve development | 2.162131e-5 |
GO:0042481 | regulation of odontogenesis | 2.195531e-5 |
GO:0043163 | cell envelope organization | 2.272029e-5 |
GO:0031627 | telomeric loop formation | 2.324623e-5 |
GO:0071593 | lymphocyte aggregation | 2.493557e-5 |
GO:0006540 | glutamate decarboxylation to succinate | 3.280186e-5 |
GO:0006817 | phosphate ion transport | 3.325799e-5 |
GO:0071109 | superior temporal gyrus development | 3.833555e-5 |
GO:0032801 | receptor catabolic process | 3.953051e-5 |
GO:0050783 | cocaine metabolic process | 4.315896e-5 |
GO:0045773 | positive regulation of axon extension | 4.392699e-5 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 4.461664e-5 |
GO:0007031 | peroxisome organization | 4.861141e-5 |
GO:0021783 | preganglionic parasympathetic nervous system development | 4.898915e-5 |
GO:0021602 | cranial nerve morphogenesis | 4.989855e-5 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 5.498782e-5 |
GO:2000627 | positive regulation of miRNA catabolic process | 5.498782e-5 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 5.498782e-5 |
GO:0000964 | mitochondrial RNA 5'-end processing | 5.498782e-5 |
GO:0016082 | synaptic vesicle priming | 5.825721e-5 |
GO:0051261 | protein depolymerization | 6.081229e-5 |
GO:0070537 | histone H2A K63-linked deubiquitination | 6.503818e-5 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 6.875841e-5 |
GO:0009817 | defense response to fungus, incompatible interaction | 6.875841e-5 |
GO:0090086 | negative regulation of protein deubiquitination | 6.923214e-5 |
GO:0006173 | dADP biosynthetic process | 6.923214e-5 |
GO:0090231 | regulation of spindle checkpoint | 6.931715e-5 |
GO:0060560 | developmental growth involved in morphogenesis | 7.004584e-5 |
GO:0048075 | positive regulation of eye pigmentation | 7.093892e-5 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 8.048225e-5 |
GO:0021603 | cranial nerve formation | 8.407294e-5 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 8.589728e-5 |
GO:0006682 | galactosylceramide biosynthetic process | 9.383044e-5 |
GO:0031081 | nuclear pore distribution | 1.099125e-4 |
GO:0043316 | cytotoxic T cell degranulation | 1.109111e-4 |
GO:0032096 | negative regulation of response to food | 1.131812e-4 |
GO:0021511 | spinal cord patterning | 1.207624e-4 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.210428e-4 |
GO:0032740 | positive regulation of interleukin-17 production | 1.215070e-4 |
GO:0046730 | induction of host immune response by virus | 1.250924e-4 |
GO:0043249 | erythrocyte maturation | 1.275446e-4 |
GO:0032108 | negative regulation of response to nutrient levels | 1.276138e-4 |
GO:0034508 | centromere complex assembly | 1.277937e-4 |
GO:0032099 | negative regulation of appetite | 1.277937e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.289908e-4 |
GO:0045116 | protein neddylation | 1.425757e-4 |
GO:0048102 | autophagic cell death | 1.425757e-4 |
GO:0006538 | glutamate catabolic process | 1.425757e-4 |
GO:0033034 | positive regulation of myeloid cell apoptosis | 1.512208e-4 |
GO:0090311 | regulation of protein deacetylation | 1.541805e-4 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 1.623632e-4 |
GO:0000965 | mitochondrial RNA 3'-end processing | 1.623632e-4 |
GO:0000958 | mitochondrial mRNA catabolic process | 1.623632e-4 |
GO:0000962 | positive regulation of mitochondrial RNA catabolic process | 1.623632e-4 |
GO:0044089 | positive regulation of cellular component biogenesis | 1.625710e-4 |
GO:0043628 | ncRNA 3'-end processing | 1.654562e-4 |
GO:0016058 | maintenance of membrane potential in photoreceptor cell by rhodopsin mediated signaling | 1.759561e-4 |
GO:0022400 | regulation of rhodopsin mediated signaling pathway | 1.759561e-4 |
GO:0006208 | pyrimidine base catabolic process | 1.863446e-4 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 1.989164e-4 |
GO:0048639 | positive regulation of developmental growth | 2.126581e-4 |
GO:0010891 | negative regulation of sequestering of triglyceride | 2.148007e-4 |
GO:0015812 | gamma-aminobutyric acid transport | 2.166933e-4 |
GO:0060603 | mammary gland duct morphogenesis | 2.182948e-4 |
GO:0006273 | lagging strand elongation | 2.230210e-4 |
GO:0030516 | regulation of axon extension | 2.364681e-4 |
GO:0021599 | abducens nerve formation | 2.445596e-4 |
GO:0016191 | synaptic vesicle uncoating | 2.445596e-4 |
GO:0007634 | optokinetic behavior | 2.445596e-4 |
GO:0015809 | arginine transport | 2.536863e-4 |
GO:0000089 | mitotic metaphase | 2.640831e-4 |
GO:0000085 | G2 phase of mitotic cell cycle | 2.654731e-4 |
GO:0061101 | neuroendocrine cell differentiation | 2.761768e-4 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 2.792394e-4 |
GO:0050805 | negative regulation of synaptic transmission | 2.830397e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 2.904741e-4 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 2.919720e-4 |
GO:0032331 | negative regulation of chondrocyte differentiation | 2.969219e-4 |
GO:0031536 | positive regulation of exit from mitosis | 3.079658e-4 |
GO:0001522 | pseudouridine synthesis | 3.079658e-4 |
GO:0042117 | monocyte activation | 3.298856e-4 |
GO:0071105 | response to interleukin-11 | 3.478891e-4 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 3.567228e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 3.589367e-4 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 3.669391e-4 |
GO:0051322 | anaphase | 3.687249e-4 |
GO:0006268 | DNA unwinding involved in replication | 3.744145e-4 |
GO:0010823 | negative regulation of mitochondrion organization | 3.779253e-4 |
GO:0046113 | nucleobase catabolic process | 3.783958e-4 |
GO:0021513 | spinal cord dorsal/ventral patterning | 3.828343e-4 |
GO:0051965 | positive regulation of synapse assembly | 4.054306e-4 |
GO:0000959 | mitochondrial RNA metabolic process | 4.148846e-4 |
GO:0001558 | regulation of cell growth | 4.262697e-4 |
GO:0007000 | nucleolus organization | 4.384864e-4 |
GO:0000022 | mitotic spindle elongation | 4.384864e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 4.411470e-4 |
GO:0016139 | glycoside catabolic process | 4.455775e-4 |
GO:0010936 | negative regulation of macrophage cytokine production | 4.540984e-4 |
GO:0070358 | actin polymerization-dependent cell motility | 4.634194e-4 |
GO:0002309 | T cell proliferation involved in immune response | 4.719572e-4 |
GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein | 4.769353e-4 |
GO:0009451 | RNA modification | 4.885772e-4 |
GO:0002513 | tolerance induction to self antigen | 5.060161e-4 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 5.274818e-4 |
GO:0071173 | spindle assembly checkpoint | 5.317449e-4 |
GO:0050432 | catecholamine secretion | 5.327348e-4 |
GO:0061102 | stomach neuroendocrine cell differentiation | 5.371919e-4 |
GO:0061100 | lung neuroendocrine cell differentiation | 5.371919e-4 |
GO:0071259 | cellular response to magnetism | 5.371919e-4 |
GO:0061104 | adrenal chromaffin cell differentiation | 5.371919e-4 |
GO:0061103 | carotid body glomus cell differentiation | 5.371919e-4 |
GO:0003359 | noradrenergic neuron fate commitment | 5.371919e-4 |
GO:0060165 | regulation of timing of subpallium neuron differentiation | 5.371919e-4 |
GO:0007400 | neuroblast fate determination | 5.371919e-4 |
GO:0048073 | regulation of eye pigmentation | 5.371919e-4 |
GO:0060163 | subpallium neuron fate commitment | 5.371919e-4 |
GO:0008334 | histone mRNA metabolic process | 5.381636e-4 |
GO:0007051 | spindle organization | 5.542627e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 5.669992e-4 |
GO:0021569 | rhombomere 3 development | 5.722740e-4 |
GO:0032984 | macromolecular complex disassembly | 5.755198e-4 |
GO:0031577 | spindle checkpoint | 5.968213e-4 |
GO:2000534 | positive regulation of renal albumin absorption | 5.989993e-4 |
GO:2000481 | positive regulation of cAMP-dependent protein kinase activity | 5.989993e-4 |
GO:0070994 | detection of oxidative stress | 5.989993e-4 |
GO:2000461 | negative regulation of eukaryotic cell surface binding | 5.989993e-4 |
GO:2000478 | positive regulation of metanephric glomerular visceral epithelial cell development | 5.989993e-4 |
GO:0048627 | myoblast development | 6.014919e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 6.116987e-4 |
GO:0035880 | embryonic nail plate morphogenesis | 6.244621e-4 |
GO:0006625 | protein targeting to peroxisome | 6.263872e-4 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 6.512660e-4 |
GO:0045649 | regulation of macrophage differentiation | 6.789031e-4 |
GO:0043129 | surfactant homeostasis | 6.849619e-4 |
GO:0052509 | positive regulation by symbiont of host defense response | 6.905140e-4 |
GO:0045820 | negative regulation of glycolysis | 7.180013e-4 |
GO:0006379 | mRNA cleavage | 7.180013e-4 |
GO:0021623 | oculomotor nerve formation | 7.200958e-4 |
GO:0003409 | optic cup structural organization | 7.200958e-4 |
GO:0003404 | optic vesicle morphogenesis | 7.200958e-4 |
GO:0061387 | regulation of extent of cell growth | 7.361449e-4 |
GO:0002418 | immune response to tumor cell | 7.436272e-4 |
GO:0060465 | pharynx development | 7.436272e-4 |
GO:0043624 | cellular protein complex disassembly | 7.691840e-4 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 7.709876e-4 |
GO:0071281 | cellular response to iron ion | 7.745258e-4 |
GO:0051970 | negative regulation of transmission of nerve impulse | 7.892388e-4 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 7.987271e-4 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 7.987271e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 7.987271e-4 |
GO:0032738 | positive regulation of interleukin-15 production | 7.987271e-4 |
GO:0048486 | parasympathetic nervous system development | 7.988989e-4 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 7.988989e-4 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 8.177327e-4 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 8.177327e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.177327e-4 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 8.177327e-4 |
GO:0051926 | negative regulation of calcium ion transport | 8.314330e-4 |
GO:0032812 | positive regulation of epinephrine secretion | 8.392231e-4 |
GO:0070253 | somatostatin secretion | 8.392231e-4 |
GO:0046683 | response to organophosphorus | 8.436078e-4 |
GO:0021545 | cranial nerve development | 8.496552e-4 |
GO:0031063 | regulation of histone deacetylation | 8.609251e-4 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 8.671099e-4 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 8.716132e-4 |
GO:0060876 | semicircular canal formation | 9.165486e-4 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 9.165486e-4 |
GO:0070574 | cadmium ion transmembrane transport | 9.271345e-4 |
GO:0017085 | response to insecticide | 9.440765e-4 |
GO:0032845 | negative regulation of homeostatic process | 9.441110e-4 |
GO:0007228 | positive regulation of hh target transcription factor activity | 9.522179e-4 |
GO:0043981 | histone H4-K5 acetylation | 9.703993e-4 |
GO:0043982 | histone H4-K8 acetylation | 9.703993e-4 |
GO:0090312 | positive regulation of protein deacetylation | 9.851551e-4 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.002847e-3 |
GO:0043932 | ossification involved in bone remodeling | 1.005937e-3 |
GO:0046724 | oxalic acid secretion | 1.027074e-3 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.027074e-3 |
GO:0043241 | protein complex disassembly | 1.031316e-3 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 1.049466e-3 |
GO:0015889 | cobalamin transport | 1.049466e-3 |
GO:0034436 | glycoprotein transport | 1.058424e-3 |
GO:0090085 | regulation of protein deubiquitination | 1.058424e-3 |
GO:0009720 | detection of hormone stimulus | 1.058424e-3 |
GO:0030573 | bile acid catabolic process | 1.067874e-3 |
GO:0060459 | left lung development | 1.079875e-3 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 1.103409e-3 |
GO:0032660 | regulation of interleukin-17 production | 1.157529e-3 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 1.175510e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 1.186386e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.190827e-3 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.211093e-3 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 1.224320e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 1.286630e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.286630e-3 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 1.310358e-3 |
GO:0043574 | peroxisomal transport | 1.326104e-3 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.327876e-3 |
GO:0045839 | negative regulation of mitosis | 1.334397e-3 |
GO:0031055 | chromatin remodeling at centromere | 1.345820e-3 |
GO:2000062 | negative regulation of ureter smooth muscle cell differentiation | 1.355073e-3 |
GO:2000063 | positive regulation of ureter smooth muscle cell differentiation | 1.355073e-3 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 1.355073e-3 |
GO:2000358 | positive regulation of kidney smooth muscle cell differentiation | 1.355073e-3 |
GO:2000357 | negative regulation of kidney smooth muscle cell differentiation | 1.355073e-3 |
GO:0080125 | multicellular structure septum development | 1.355073e-3 |
GO:0007502 | digestive tract mesoderm development | 1.355073e-3 |
GO:0060783 | mesenchymal smoothened signaling pathway involved in prostate gland development | 1.355073e-3 |
GO:0014858 | positive regulation of skeletal muscle cell proliferation | 1.355073e-3 |
GO:0060782 | regulation of mesenchymal cell proliferation involved in prostate gland development | 1.355073e-3 |
GO:0046534 | positive regulation of photoreceptor cell differentiation | 1.355073e-3 |
GO:0022037 | metencephalon development | 1.356395e-3 |
GO:0070206 | protein trimerization | 1.398495e-3 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.423822e-3 |
GO:0022616 | DNA strand elongation | 1.435988e-3 |
GO:0060447 | bud outgrowth involved in lung branching | 1.460716e-3 |
GO:0008361 | regulation of cell size | 1.497281e-3 |
GO:0031645 | negative regulation of neurological system process | 1.514767e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.533228e-3 |
GO:0018212 | peptidyl-tyrosine modification | 1.538934e-3 |
GO:0070172 | positive regulation of tooth mineralization | 1.573638e-3 |
GO:0006013 | mannose metabolic process | 1.588802e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.596990e-3 |
GO:0021546 | rhombomere development | 1.617242e-3 |
GO:0070207 | protein homotrimerization | 1.617557e-3 |
GO:0019083 | viral transcription | 1.653667e-3 |
GO:0018065 | protein-cofactor linkage | 1.691000e-3 |
GO:0010887 | negative regulation of cholesterol storage | 1.698060e-3 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 1.699102e-3 |
GO:0006272 | leading strand elongation | 1.708729e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 1.721607e-3 |
GO:0051586 | positive regulation of dopamine uptake | 1.768199e-3 |
GO:0010722 | regulation of ferrochelatase activity | 1.768199e-3 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 1.789576e-3 |
GO:0006528 | asparagine metabolic process | 1.789576e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 1.812750e-3 |
GO:0045684 | positive regulation of epidermis development | 1.813801e-3 |
GO:0044341 | sodium-dependent phosphate transport | 1.820138e-3 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 1.834717e-3 |
GO:0010043 | response to zinc ion | 1.877550e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 1.881569e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.945116e-3 |
GO:0071279 | cellular response to cobalt ion | 1.945116e-3 |
GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 1.945116e-3 |
GO:0001957 | intramembranous ossification | 1.965664e-3 |
GO:0060659 | nipple sheath formation | 1.977622e-3 |
GO:0060649 | mammary gland bud elongation | 1.977622e-3 |
GO:0043525 | positive regulation of neuron apoptosis | 1.983835e-3 |
GO:0000712 | resolution of meiotic recombination intermediates | 1.996118e-3 |
GO:0007019 | microtubule depolymerization | 2.036111e-3 |
GO:0010832 | negative regulation of myotube differentiation | 2.040480e-3 |
GO:0045776 | negative regulation of blood pressure | 2.062724e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 2.131984e-3 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 2.154971e-3 |
GO:0031860 | telomeric 3' overhang formation | 2.176356e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 2.176356e-3 |
GO:0071422 | succinate transmembrane transport | 2.216892e-3 |
GO:0042489 | negative regulation of odontogenesis of dentine-containing tooth | 2.302978e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 2.302978e-3 |
GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 2.416355e-3 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 2.416355e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 2.487436e-3 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 2.525576e-3 |
GO:0009066 | aspartate family amino acid metabolic process | 2.578852e-3 |
GO:0021592 | fourth ventricle development | 2.632474e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 2.679871e-3 |
GO:0071585 | detoxification of cadmium ion | 2.689748e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 2.692537e-3 |
GO:0048840 | otolith development | 2.736897e-3 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 2.874974e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 2.889922e-3 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 2.891072e-3 |
GO:0000090 | mitotic anaphase | 2.938302e-3 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.964323e-3 |
GO:0034616 | response to laminar fluid shear stress | 2.964323e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 3.053008e-3 |
GO:0070060 | 'de novo' actin filament nucleation | 3.073662e-3 |
GO:0006529 | asparagine biosynthetic process | 3.073662e-3 |
GO:0045200 | establishment of neuroblast polarity | 3.093603e-3 |
GO:0009229 | thiamine diphosphate biosynthetic process | 3.093603e-3 |
GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response | 3.093603e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 3.112119e-3 |
GO:0046425 | regulation of JAK-STAT cascade | 3.118795e-3 |
GO:0060516 | primary prostatic bud elongation | 3.120438e-3 |
GO:0071850 | mitotic cell cycle arrest | 3.215995e-3 |
GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation | 3.215995e-3 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 3.303992e-3 |
GO:0045792 | negative regulation of cell size | 3.347794e-3 |
GO:0090232 | positive regulation of spindle checkpoint | 3.347794e-3 |
GO:0006546 | glycine catabolic process | 3.347794e-3 |
GO:0048859 | formation of anatomical boundary | 3.370931e-3 |
GO:0007418 | ventral midline development | 3.370931e-3 |
GO:0001553 | luteinization | 3.391321e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 3.411775e-3 |
GO:0030308 | negative regulation of cell growth | 3.446284e-3 |
GO:0021521 | ventral spinal cord interneuron specification | 3.453076e-3 |
GO:0031297 | replication fork processing | 3.464605e-3 |
GO:0019049 | evasion of host defenses by virus | 3.464605e-3 |
GO:0042482 | positive regulation of odontogenesis | 3.502283e-3 |
GO:0070925 | organelle assembly | 3.535627e-3 |
GO:0015701 | bicarbonate transport | 3.579874e-3 |
GO:0034214 | protein hexamerization | 3.588819e-3 |
GO:0033058 | directional locomotion | 3.588819e-3 |
GO:0019058 | viral infectious cycle | 3.601039e-3 |
GO:0006260 | DNA replication | 3.632540e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 3.634728e-3 |
GO:0060611 | mammary gland fat development | 3.634728e-3 |
GO:0006415 | translational termination | 3.671608e-3 |
GO:0019695 | choline metabolic process | 3.680622e-3 |
GO:0060349 | bone morphogenesis | 3.702296e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 3.709831e-3 |
GO:0043268 | positive regulation of potassium ion transport | 3.779267e-3 |
GO:0016233 | telomere capping | 3.862735e-3 |
GO:0033004 | negative regulation of mast cell activation | 3.910611e-3 |
GO:0031427 | response to methotrexate | 3.923223e-3 |
GO:0035458 | cellular response to interferon-beta | 3.926343e-3 |
GO:0031123 | RNA 3'-end processing | 3.952169e-3 |
GO:0002052 | positive regulation of neuroblast proliferation | 4.017832e-3 |
GO:0021549 | cerebellum development | 4.019104e-3 |
GO:0002369 | T cell cytokine production | 4.023294e-3 |
GO:0010742 | macrophage derived foam cell differentiation | 4.023294e-3 |
GO:0031125 | rRNA 3'-end processing | 4.040336e-3 |
GO:0032571 | response to vitamin K | 4.040336e-3 |
GO:0021568 | rhombomere 2 development | 4.040336e-3 |
GO:0016539 | intein-mediated protein splicing | 4.040336e-3 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 4.087288e-3 |
GO:0006105 | succinate metabolic process | 4.107183e-3 |
GO:0016560 | protein import into peroxisome matrix, docking | 4.130400e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 4.130400e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 4.136237e-3 |
GO:0090218 | positive regulation of lipid kinase activity | 4.196352e-3 |
GO:0033205 | cell cycle cytokinesis | 4.208411e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 4.228068e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 4.316854e-3 |
GO:0051320 | S phase | 4.346831e-3 |
GO:0050769 | positive regulation of neurogenesis | 4.431811e-3 |
GO:0048705 | skeletal system morphogenesis | 4.547801e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 4.550372e-3 |
GO:0006828 | manganese ion transport | 4.550372e-3 |
GO:0060484 | lung-associated mesenchyme development | 4.559578e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 4.574026e-3 |
GO:0042780 | tRNA 3'-end processing | 4.614312e-3 |
GO:0010734 | negative regulation of protein glutathionylation | 4.614312e-3 |
GO:0001778 | plasma membrane repair | 4.620432e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 4.627018e-3 |
GO:0050931 | pigment cell differentiation | 4.702177e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 4.758917e-3 |
GO:0045682 | regulation of epidermis development | 4.796301e-3 |
GO:0006607 | NLS-bearing substrate import into nucleus | 4.807264e-3 |
GO:0021697 | cerebellar cortex formation | 4.817974e-3 |
GO:0044070 | regulation of anion transport | 4.863494e-3 |
GO:0032922 | circadian regulation of gene expression | 4.886460e-3 |
GO:0021526 | medial motor column neuron differentiation | 4.902694e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 4.933848e-3 |
GO:0015886 | heme transport | 5.089333e-3 |
GO:0008210 | estrogen metabolic process | 5.095822e-3 |
GO:0048808 | male genitalia morphogenesis | 5.133366e-3 |
GO:0007262 | STAT protein import into nucleus | 5.135847e-3 |
GO:0021523 | somatic motor neuron differentiation | 5.135847e-3 |
GO:0005983 | starch catabolic process | 5.135925e-3 |
GO:0006172 | ADP biosynthetic process | 5.159280e-3 |
GO:0000966 | RNA 5'-end processing | 5.159280e-3 |
GO:0030953 | astral microtubule organization | 5.219233e-3 |
GO:0002357 | defense response to tumor cell | 5.325004e-3 |
GO:0008057 | eye pigment granule organization | 5.468644e-3 |
GO:0046031 | ADP metabolic process | 5.482145e-3 |
GO:0015844 | monoamine transport | 5.482957e-3 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 5.524184e-3 |
GO:0001579 | medium-chain fatty acid transport | 5.583526e-3 |
GO:0060648 | mammary gland bud morphogenesis | 5.603128e-3 |
GO:0031065 | positive regulation of histone deacetylation | 5.755708e-3 |
GO:0030852 | regulation of granulocyte differentiation | 5.836010e-3 |
GO:0035284 | brain segmentation | 5.993242e-3 |
GO:0072075 | metanephric mesenchyme development | 6.049360e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 6.087865e-3 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 6.132594e-3 |
GO:0021587 | cerebellum morphogenesis | 6.239969e-3 |
GO:0003416 | endochondral bone growth | 6.242240e-3 |
GO:0045616 | regulation of keratinocyte differentiation | 6.277464e-3 |
GO:0016137 | glycoside metabolic process | 6.484638e-3 |
GO:0015802 | basic amino acid transport | 6.565195e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 6.617607e-3 |
GO:0030309 | poly-N-acetyllactosamine metabolic process | 6.688732e-3 |
GO:0048676 | axon extension involved in development | 6.698452e-3 |
GO:0050873 | brown fat cell differentiation | 6.699812e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 6.713499e-3 |
GO:0002115 | store-operated calcium entry | 6.713499e-3 |
GO:0051937 | catecholamine transport | 6.729126e-3 |
GO:0021514 | ventral spinal cord interneuron differentiation | 6.950944e-3 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 6.976440e-3 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 6.976440e-3 |
GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep | 7.058743e-3 |
GO:0002076 | osteoblast development | 7.088888e-3 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 7.177333e-3 |
GO:0003105 | negative regulation of glomerular filtration | 7.203547e-3 |
GO:0043320 | natural killer cell degranulation | 7.236779e-3 |
GO:0021558 | trochlear nerve development | 7.236779e-3 |
GO:0006836 | neurotransmitter transport | 7.266065e-3 |
GO:0043983 | histone H4-K12 acetylation | 7.358811e-3 |
GO:0060602 | branch elongation of an epithelium | 7.420618e-3 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 7.510580e-3 |
GO:0022415 | viral reproductive process | 7.516724e-3 |
GO:0072060 | outer medullary collecting duct development | 7.557900e-3 |
GO:0072061 | inner medullary collecting duct development | 7.557900e-3 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 7.557900e-3 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 7.600713e-3 |
GO:0006401 | RNA catabolic process | 7.608025e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 7.638004e-3 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 7.680213e-3 |
GO:0045650 | negative regulation of macrophage differentiation | 7.853433e-3 |
GO:0021559 | trigeminal nerve development | 7.861912e-3 |
GO:0060535 | trachea cartilage morphogenesis | 8.093918e-3 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 8.100058e-3 |
GO:0060242 | contact inhibition | 8.100058e-3 |
GO:0021533 | cell differentiation in hindbrain | 8.105529e-3 |
GO:0045618 | positive regulation of keratinocyte differentiation | 8.314318e-3 |
GO:0048818 | positive regulation of hair follicle maturation | 8.314318e-3 |
GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 8.314318e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 8.387440e-3 |
GO:0009436 | glyoxylate catabolic process | 8.389402e-3 |
GO:0070170 | regulation of tooth mineralization | 8.459906e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 8.481756e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 8.679398e-3 |
GO:0001836 | release of cytochrome c from mitochondria | 8.699592e-3 |
GO:0006353 | transcription termination, DNA-dependent | 8.801539e-3 |
GO:0045066 | regulatory T cell differentiation | 8.820488e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 8.992013e-3 |
GO:0061180 | mammary gland epithelium development | 8.996625e-3 |
GO:0070723 | response to cholesterol | 9.072373e-3 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 9.094924e-3 |
GO:0006390 | transcription from mitochondrial promoter | 9.246797e-3 |
GO:0010869 | regulation of receptor biosynthetic process | 9.295772e-3 |
GO:0002071 | glandular epithelial cell maturation | 9.342247e-3 |
GO:0000917 | barrier septum formation | 9.342247e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 9.466464e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 9.530652e-3 |
GO:0070194 | synaptonemal complex disassembly | 9.530652e-3 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 9.668510e-3 |
GO:0060923 | cardiac muscle cell fate commitment | 9.698747e-3 |
GO:0021678 | third ventricle development | 9.698747e-3 |
GO:0035313 | wound healing, spreading of epidermal cells | 9.709167e-3 |
GO:0034728 | nucleosome organization | 9.768247e-3 |
GO:0010821 | regulation of mitochondrion organization | 9.769275e-3 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 9.784857e-3 |
GO:0060359 | response to ammonium ion | 9.792952e-3 |
GO:0050716 | positive regulation of interleukin-1 secretion | 9.855040e-3 |
GO:0000093 | mitotic telophase | 9.925068e-3 |
GO:0006402 | mRNA catabolic process | 9.962436e-3 |
GO:0005978 | glycogen biosynthetic process | 9.987531e-3 |
GO:0010452 | histone H3-K36 methylation | 1.006924e-2 |
GO:0000271 | polysaccharide biosynthetic process | 1.012127e-2 |
GO:0018022 | peptidyl-lysine methylation | 1.024238e-2 |
GO:0005993 | trehalose catabolic process | 1.037645e-2 |
GO:0016559 | peroxisome fission | 1.037645e-2 |
GO:0042273 | ribosomal large subunit biogenesis | 1.043942e-2 |
GO:0033032 | regulation of myeloid cell apoptosis | 1.067165e-2 |
GO:0033504 | floor plate development | 1.072030e-2 |
GO:0032095 | regulation of response to food | 1.072973e-2 |
GO:0020028 | hemoglobin import | 1.094037e-2 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 1.114401e-2 |
GO:0014719 | satellite cell activation | 1.114401e-2 |
GO:0051795 | positive regulation of catagen | 1.128677e-2 |
GO:0019227 | neuronal action potential propagation | 1.137168e-2 |
GO:0001561 | fatty acid alpha-oxidation | 1.140203e-2 |
GO:0045343 | regulation of MHC class I biosynthetic process | 1.151356e-2 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 1.152941e-2 |
GO:0033133 | positive regulation of glucokinase activity | 1.163294e-2 |
GO:0021575 | hindbrain morphogenesis | 1.165367e-2 |
GO:2001044 | regulation of integrin-mediated signaling pathway | 1.174481e-2 |
GO:0032474 | otolith morphogenesis | 1.174481e-2 |
GO:0006741 | NADP biosynthetic process | 1.174481e-2 |
GO:0021532 | neural tube patterning | 1.200423e-2 |
GO:0006333 | chromatin assembly or disassembly | 1.208699e-2 |
GO:0031659 | positive regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.209366e-2 |
GO:0030318 | melanocyte differentiation | 1.213336e-2 |
GO:0009636 | response to toxin | 1.219456e-2 |
GO:0021571 | rhombomere 5 development | 1.247672e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0060923 | cardiac muscle cell fate commitment | 2.086099e-10 |
GO:0060911 | cardiac cell fate commitment | 1.313870e-8 |
GO:0090083 | regulation of inclusion body assembly | 2.052600e-8 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 3.248306e-8 |
GO:0060299 | negative regulation of sarcomere organization | 3.248306e-8 |
GO:0060932 | His-Purkinje system cell differentiation | 4.692870e-8 |
GO:0060926 | pacemaker cell development | 4.692870e-8 |
GO:0060920 | pacemaker cell differentiation | 9.010162e-8 |
GO:0010159 | specification of organ position | 1.539555e-7 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 1.066657e-6 |
GO:0090084 | negative regulation of inclusion body assembly | 1.101375e-6 |
GO:0003163 | sinoatrial node development | 1.358790e-6 |
GO:0003167 | atrioventricular bundle cell differentiation | 1.562217e-6 |
GO:0060931 | sinoatrial node cell development | 1.562217e-6 |
GO:0032094 | response to food | 1.690144e-6 |
GO:0006012 | galactose metabolic process | 1.722919e-6 |
GO:0060047 | heart contraction | 1.742472e-6 |
GO:0060921 | sinoatrial node cell differentiation | 2.723834e-6 |
GO:0005981 | regulation of glycogen catabolic process | 2.902760e-6 |
GO:0070842 | aggresome assembly | 4.094571e-6 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.205097e-6 |
GO:0003161 | cardiac conduction system development | 7.116796e-6 |
GO:0034260 | negative regulation of GTPase activity | 7.950292e-6 |
GO:0060048 | cardiac muscle contraction | 8.768935e-6 |
GO:0034421 | post-translational protein acetylation | 9.748536e-6 |
GO:0030382 | sperm mitochondrion organization | 1.041893e-5 |
GO:0003166 | bundle of His development | 1.476667e-5 |
GO:0021586 | pons maturation | 1.526136e-5 |
GO:0090231 | regulation of spindle checkpoint | 1.738287e-5 |
GO:0033005 | positive regulation of mast cell activation | 1.903001e-5 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.089295e-5 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.089295e-5 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 2.089295e-5 |
GO:0032707 | negative regulation of interleukin-23 production | 2.089295e-5 |
GO:0032757 | positive regulation of interleukin-8 production | 2.154938e-5 |
GO:0043306 | positive regulation of mast cell degranulation | 2.426067e-5 |
GO:0034509 | centromeric core chromatin assembly | 2.432284e-5 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 2.432284e-5 |
GO:0019285 | glycine betaine biosynthetic process from choline | 2.745192e-5 |
GO:0032275 | luteinizing hormone secretion | 3.743055e-5 |
GO:0046884 | follicle-stimulating hormone secretion | 3.743055e-5 |
GO:0003015 | heart process | 3.859303e-5 |
GO:0042339 | keratan sulfate metabolic process | 4.494210e-5 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 4.880225e-5 |
GO:0018364 | peptidyl-glutamine methylation | 5.095311e-5 |
GO:0032647 | regulation of interferon-alpha production | 5.645614e-5 |
GO:0032648 | regulation of interferon-beta production | 5.996517e-5 |
GO:0032218 | riboflavin transport | 6.042099e-5 |
GO:0043302 | positive regulation of leukocyte degranulation | 6.690968e-5 |
GO:0035802 | adrenal cortex formation | 6.700499e-5 |
GO:0045359 | positive regulation of interferon-beta biosynthetic process | 8.335831e-5 |
GO:0042398 | cellular modified amino acid biosynthetic process | 9.246972e-5 |
GO:0090086 | negative regulation of protein deubiquitination | 1.163433e-4 |
GO:2000491 | positive regulation of hepatic stellate cell activation | 1.304200e-4 |
GO:0021935 | cerebellar granule cell precursor tangential migration | 1.304200e-4 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 1.308520e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.313793e-4 |
GO:0090192 | regulation of glomerulus development | 1.415679e-4 |
GO:0019255 | glucose 1-phosphate metabolic process | 1.608371e-4 |
GO:0033578 | protein glycosylation in Golgi | 1.631719e-4 |
GO:0045964 | positive regulation of dopamine metabolic process | 1.761115e-4 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 1.803254e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.803254e-4 |
GO:0006825 | copper ion transport | 2.039550e-4 |
GO:0001880 | Mullerian duct regression | 2.186412e-4 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 2.902402e-4 |
GO:0051586 | positive regulation of dopamine uptake | 2.979498e-4 |
GO:0060216 | definitive hemopoiesis | 3.281213e-4 |
GO:0051775 | response to redox state | 3.350617e-4 |
GO:0008355 | olfactory learning | 3.350617e-4 |
GO:0006409 | tRNA export from nucleus | 3.582389e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 3.582389e-4 |
GO:0031329 | regulation of cellular catabolic process | 3.610868e-4 |
GO:0007405 | neuroblast proliferation | 3.802538e-4 |
GO:0051150 | regulation of smooth muscle cell differentiation | 4.033242e-4 |
GO:0072298 | regulation of metanephric glomerulus development | 4.388178e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 4.524721e-4 |
GO:0006413 | translational initiation | 4.559308e-4 |
GO:0021998 | neural plate mediolateral regionalization | 4.574470e-4 |
GO:0048352 | paraxial mesoderm structural organization | 4.574470e-4 |
GO:0048672 | positive regulation of collateral sprouting | 4.980384e-4 |
GO:0032479 | regulation of type I interferon production | 5.182391e-4 |
GO:0006089 | lactate metabolic process | 5.186043e-4 |
GO:0032781 | positive regulation of ATPase activity | 5.267100e-4 |
GO:0033121 | regulation of purine nucleotide catabolic process | 5.996707e-4 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 6.395157e-4 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 6.598751e-4 |
GO:0016559 | peroxisome fission | 6.671652e-4 |
GO:0016557 | peroxisome membrane biogenesis | 7.501122e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.869184e-4 |
GO:0006030 | chitin metabolic process | 8.074323e-4 |
GO:0002418 | immune response to tumor cell | 8.180551e-4 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 8.180551e-4 |
GO:0051103 | DNA ligation involved in DNA repair | 8.317026e-4 |
GO:0032849 | positive regulation of cellular pH reduction | 8.463357e-4 |
GO:2000426 | negative regulation of apoptotic cell clearance | 8.481007e-4 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 8.636409e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 8.636409e-4 |
GO:0006258 | UDP-glucose catabolic process | 8.636409e-4 |
GO:0016578 | histone deubiquitination | 9.099897e-4 |
GO:0035115 | embryonic forelimb morphogenesis | 9.155825e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 9.582277e-4 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 1.011046e-3 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.061562e-3 |
GO:0015670 | carbon dioxide transport | 1.075018e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1.077179e-3 |
GO:0048670 | regulation of collateral sprouting | 1.122847e-3 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 1.123680e-3 |
GO:0007356 | thorax and anterior abdomen determination | 1.123680e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.123680e-3 |
GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 1.188836e-3 |
GO:0035412 | regulation of catenin import into nucleus | 1.207048e-3 |
GO:0009081 | branched chain family amino acid metabolic process | 1.232963e-3 |
GO:0030539 | male genitalia development | 1.234763e-3 |
GO:0022904 | respiratory electron transport chain | 1.269853e-3 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 1.344247e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 1.357354e-3 |
GO:0043407 | negative regulation of MAP kinase activity | 1.403621e-3 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 1.413236e-3 |
GO:0043457 | regulation of cellular respiration | 1.429080e-3 |
GO:0021502 | neural fold elevation formation | 1.429080e-3 |
GO:0000212 | meiotic spindle organization | 1.429080e-3 |
GO:0032274 | gonadotropin secretion | 1.446784e-3 |
GO:0032727 | positive regulation of interferon-alpha production | 1.449304e-3 |
GO:0045662 | negative regulation of myoblast differentiation | 1.460525e-3 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 1.462917e-3 |
GO:0006658 | phosphatidylserine metabolic process | 1.462917e-3 |
GO:0006266 | DNA ligation | 1.462917e-3 |
GO:0035417 | negative regulation of mitotic prometaphase | 1.556272e-3 |
GO:0048382 | mesendoderm development | 1.631821e-3 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 1.657360e-3 |
GO:0035887 | aortic smooth muscle cell differentiation | 1.809702e-3 |
GO:0051494 | negative regulation of cytoskeleton organization | 1.812346e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 1.818593e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 1.831113e-3 |
GO:0051639 | actin filament network formation | 1.846162e-3 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 1.846162e-3 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.846162e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 1.890894e-3 |
GO:0031584 | activation of phospholipase D activity | 1.919332e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.947915e-3 |
GO:0002537 | nitric oxide production involved in inflammatory response | 2.008533e-3 |
GO:0032370 | positive regulation of lipid transport | 2.061128e-3 |
GO:0048671 | negative regulation of collateral sprouting | 2.089224e-3 |
GO:0043087 | regulation of GTPase activity | 2.117972e-3 |
GO:0002561 | basophil degranulation | 2.227656e-3 |
GO:0002357 | defense response to tumor cell | 2.227656e-3 |
GO:0071545 | inositol phosphate catabolic process | 2.240834e-3 |
GO:0001841 | neural tube formation | 2.262220e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 2.274689e-3 |
GO:0033124 | regulation of GTP catabolic process | 2.297836e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.305902e-3 |
GO:0072015 | glomerular visceral epithelial cell development | 2.305902e-3 |
GO:0051301 | cell division | 2.376688e-3 |
GO:0033006 | regulation of mast cell activation involved in immune response | 2.461752e-3 |
GO:0021535 | cell migration in hindbrain | 2.471840e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.487167e-3 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 2.633071e-3 |
GO:0010875 | positive regulation of cholesterol efflux | 2.762696e-3 |
GO:0033261 | regulation of S phase | 2.782538e-3 |
GO:0046599 | regulation of centriole replication | 2.820586e-3 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 3.034025e-3 |
GO:0046488 | phosphatidylinositol metabolic process | 3.069504e-3 |
GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 3.117217e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.171848e-3 |
GO:0046755 | non-lytic virus budding | 3.171848e-3 |
GO:0006551 | leucine metabolic process | 3.179639e-3 |
GO:0002092 | positive regulation of receptor internalization | 3.225280e-3 |
GO:0032728 | positive regulation of interferon-beta production | 3.353132e-3 |
GO:0042254 | ribosome biogenesis | 3.376100e-3 |
GO:0043687 | post-translational protein modification | 3.523526e-3 |
GO:0051129 | negative regulation of cellular component organization | 3.749685e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 3.783785e-3 |
GO:0006578 | betaine biosynthetic process | 3.783785e-3 |
GO:0003197 | endocardial cushion development | 3.911470e-3 |
GO:0046855 | inositol phosphate dephosphorylation | 3.991549e-3 |
GO:0034470 | ncRNA processing | 4.036844e-3 |
GO:0017148 | negative regulation of translation | 4.049010e-3 |
GO:0016180 | snRNA processing | 4.120089e-3 |
GO:0033523 | histone H2B ubiquitination | 4.166035e-3 |
GO:2000425 | regulation of apoptotic cell clearance | 4.246861e-3 |
GO:0010948 | negative regulation of cell cycle process | 4.247908e-3 |
GO:0071529 | cementum mineralization | 4.289464e-3 |
GO:0090085 | regulation of protein deubiquitination | 4.289464e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 4.290344e-3 |
GO:0006561 | proline biosynthetic process | 4.290344e-3 |
GO:0007614 | short-term memory | 4.617966e-3 |
GO:0035117 | embryonic arm morphogenesis | 4.670463e-3 |
GO:0003156 | regulation of organ formation | 4.682851e-3 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 4.709068e-3 |
GO:0006288 | base-excision repair, DNA ligation | 4.714893e-3 |
GO:0006032 | chitin catabolic process | 4.714893e-3 |
GO:0009236 | cobalamin biosynthetic process | 4.720211e-3 |
GO:0022400 | regulation of rhodopsin mediated signaling pathway | 4.720211e-3 |
GO:0045575 | basophil activation | 4.720211e-3 |
GO:0019047 | provirus integration | 4.720211e-3 |
GO:0051147 | regulation of muscle cell differentiation | 4.741385e-3 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 4.771797e-3 |
GO:0045661 | regulation of myoblast differentiation | 5.071648e-3 |
GO:0010874 | regulation of cholesterol efflux | 5.086449e-3 |
GO:0032776 | DNA methylation on cytosine | 5.149903e-3 |
GO:0043966 | histone H3 acetylation | 5.265681e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 5.275424e-3 |
GO:0050861 | positive regulation of B cell receptor signaling pathway | 5.275424e-3 |
GO:0043304 | regulation of mast cell degranulation | 5.423789e-3 |
GO:0048368 | lateral mesoderm development | 5.432376e-3 |
GO:0002318 | myeloid progenitor cell differentiation | 5.501464e-3 |
GO:0030046 | parallel actin filament bundle assembly | 5.506675e-3 |
GO:0015705 | iodide transport | 5.506675e-3 |
GO:0034661 | ncRNA catabolic process | 5.546901e-3 |
GO:0014020 | primary neural tube formation | 5.624161e-3 |
GO:0001947 | heart looping | 5.644070e-3 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 5.676743e-3 |
GO:0016925 | protein sumoylation | 5.778012e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 5.780129e-3 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 5.881998e-3 |
GO:0046434 | organophosphate catabolic process | 5.884415e-3 |
GO:0034261 | negative regulation of Ras GTPase activity | 6.199279e-3 |
GO:0032376 | positive regulation of cholesterol transport | 6.228449e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 6.318746e-3 |
GO:0052556 | positive regulation by symbiont of host immune response | 6.407448e-3 |
GO:0003285 | septum secundum development | 6.407448e-3 |
GO:0052509 | positive regulation by symbiont of host defense response | 6.407448e-3 |
GO:0030902 | hindbrain development | 6.431133e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 6.448480e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 6.718224e-3 |
GO:0060179 | male mating behavior | 6.893674e-3 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 6.893674e-3 |
GO:0006097 | glyoxylate cycle | 6.893674e-3 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 6.974225e-3 |
GO:0043482 | cellular pigment accumulation | 7.025789e-3 |
GO:0022037 | metencephalon development | 7.158845e-3 |
GO:0042274 | ribosomal small subunit biogenesis | 7.346811e-3 |
GO:0052033 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immunity | 7.379224e-3 |
GO:0010587 | miRNA catabolic process | 7.379224e-3 |
GO:0051541 | elastin metabolic process | 7.410599e-3 |
GO:2000297 | negative regulation of synapse maturation | 7.448763e-3 |
GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 7.448763e-3 |
GO:0042048 | olfactory behavior | 7.448763e-3 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 7.448763e-3 |
GO:0048532 | anatomical structure arrangement | 7.565326e-3 |
GO:0001759 | organ induction | 7.565326e-3 |
GO:0070244 | negative regulation of thymocyte apoptosis | 7.609832e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 7.610929e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 7.885005e-3 |
GO:0032264 | IMP salvage | 8.187269e-3 |
GO:0046038 | GMP catabolic process | 8.187269e-3 |
GO:0023035 | CD40 signaling pathway | 8.187269e-3 |
GO:0006178 | guanine salvage | 8.187269e-3 |
GO:0032263 | GMP salvage | 8.187269e-3 |
GO:0043576 | regulation of respiratory gaseous exchange | 8.232761e-3 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 8.462527e-3 |
GO:0060155 | platelet dense granule organization | 8.471328e-3 |
GO:0060928 | atrioventricular node cell development | 8.576781e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 8.576781e-3 |
GO:0006844 | acyl carnitine transport | 8.576781e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 8.576781e-3 |
GO:0002462 | tolerance induction to nonself antigen | 8.576781e-3 |
GO:0003342 | proepicardium development | 8.576781e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 8.717617e-3 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 8.723083e-3 |
GO:0000422 | mitochondrion degradation | 8.723083e-3 |
GO:0060159 | regulation of dopamine receptor signaling pathway | 8.778265e-3 |
GO:0043388 | positive regulation of DNA binding | 9.071650e-3 |
GO:0001838 | embryonic epithelial tube formation | 9.094023e-3 |
GO:0000085 | G2 phase of mitotic cell cycle | 9.611307e-3 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 9.622464e-3 |
GO:0072192 | ureter epithelial cell differentiation | 9.622464e-3 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 9.622464e-3 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 9.622464e-3 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 9.622464e-3 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 9.622464e-3 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 9.622464e-3 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 9.622464e-3 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 9.622464e-3 |
GO:0090194 | negative regulation of glomerulus development | 9.622464e-3 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 9.622464e-3 |
GO:0007500 | mesodermal cell fate determination | 9.622464e-3 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 9.622464e-3 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 9.622464e-3 |
GO:0048392 | intermediate mesodermal cell differentiation | 9.622464e-3 |
GO:0006481 | C-terminal protein methylation | 9.622464e-3 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 9.622464e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 9.622464e-3 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 9.622464e-3 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 9.622464e-3 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 9.622464e-3 |
GO:0060503 | bud dilation involved in lung branching | 9.622464e-3 |
GO:0051153 | regulation of striated muscle cell differentiation | 9.661225e-3 |
GO:0031128 | developmental induction | 9.764634e-3 |
GO:0035928 | rRNA import into mitochondrion | 9.848843e-3 |
GO:0019388 | galactose catabolic process | 9.848843e-3 |
GO:0009268 | response to pH | 9.863759e-3 |
GO:0045454 | cell redox homeostasis | 1.000354e-2 |
GO:0060396 | growth hormone receptor signaling pathway | 1.003247e-2 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 1.008302e-2 |
GO:0033205 | cell cycle cytokinesis | 1.008448e-2 |
GO:0007252 | I-kappaB phosphorylation | 1.017909e-2 |
GO:0001675 | acrosome assembly | 1.017909e-2 |
GO:0032025 | response to cobalt ion | 1.030857e-2 |
GO:0003350 | pulmonary myocardium development | 1.030857e-2 |
GO:0060449 | bud elongation involved in lung branching | 1.038408e-2 |
GO:0033363 | secretory granule organization | 1.073903e-2 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 1.110521e-2 |
GO:0046856 | phosphatidylinositol dephosphorylation | 1.112479e-2 |
GO:0072215 | regulation of metanephros development | 1.123407e-2 |
GO:0000266 | mitochondrial fission | 1.141802e-2 |
GO:0002224 | toll-like receptor signaling pathway | 1.141802e-2 |
GO:0016073 | snRNA metabolic process | 1.144346e-2 |
GO:0006941 | striated muscle contraction | 1.159527e-2 |
GO:0016358 | dendrite development | 1.163538e-2 |
GO:0048486 | parasympathetic nervous system development | 1.165010e-2 |
GO:0002221 | pattern recognition receptor signaling pathway | 1.181578e-2 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 1.204225e-2 |
GO:0071711 | basement membrane organization | 1.204225e-2 |
GO:0090238 | positive regulation of arachidonic acid secretion | 1.204898e-2 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 1.204898e-2 |
GO:0018095 | protein polyglutamylation | 1.204898e-2 |
GO:0002138 | retinoic acid biosynthetic process | 1.204898e-2 |
GO:0071378 | cellular response to growth hormone stimulus | 1.205930e-2 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 1.210318e-2 |
GO:0021602 | cranial nerve morphogenesis | 1.214799e-2 |
GO:0061113 | pancreas morphogenesis | 1.217969e-2 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 1.217969e-2 |
GO:0034660 | ncRNA metabolic process | 1.218415e-2 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.248513e-2 |
GO:0072175 | epithelial tube formation | 1.262439e-2 |
GO:0046129 | purine ribonucleoside biosynthetic process | 1.267591e-2 |
GO:0060427 | lung connective tissue development | 1.276662e-2 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 1.298320e-2 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.298320e-2 |
GO:0034394 | protein localization at cell surface | 1.299924e-2 |
GO:2000171 | negative regulation of dendrite development | 1.319090e-2 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 1.343029e-2 |
GO:0090187 | positive regulation of pancreatic juice secretion | 1.343029e-2 |
GO:0006393 | termination of mitochondrial transcription | 1.343029e-2 |
GO:0060847 | endothelial cell fate specification | 1.343029e-2 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 1.343029e-2 |
GO:2000018 | regulation of male gonad development | 1.354484e-2 |
GO:0031331 | positive regulation of cellular catabolic process | 1.384928e-2 |
GO:0070734 | histone H3-K27 methylation | 1.391012e-2 |
GO:0061156 | pulmonary artery morphogenesis | 1.391012e-2 |
GO:0030836 | positive regulation of actin filament depolymerization | 1.391012e-2 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.398479e-2 |
GO:0042417 | dopamine metabolic process | 1.400340e-2 |
GO:0071882 | activation of phospholipase C activity by adrenergic receptor signaling pathway | 1.403234e-2 |
GO:0071881 | inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway | 1.403234e-2 |
GO:0016331 | morphogenesis of embryonic epithelium | 1.415577e-2 |
GO:0006346 | methylation-dependent chromatin silencing | 1.420388e-2 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 1.420388e-2 |
GO:0016082 | synaptic vesicle priming | 1.420842e-2 |
GO:0006546 | glycine catabolic process | 1.420842e-2 |
GO:0042773 | ATP synthesis coupled electron transport | 1.425077e-2 |
GO:0060390 | regulation of SMAD protein import into nucleus | 1.455933e-2 |
GO:0060729 | intestinal epithelial structure maintenance | 1.479598e-2 |
GO:0002282 | microglial cell activation involved in immune response | 1.479598e-2 |
GO:0009894 | regulation of catabolic process | 1.503698e-2 |
GO:0048285 | organelle fission | 1.510390e-2 |
GO:0016072 | rRNA metabolic process | 1.532057e-2 |
GO:0010639 | negative regulation of organelle organization | 1.536475e-2 |
GO:0060754 | positive regulation of mast cell chemotaxis | 1.555061e-2 |
GO:0001661 | conditioned taste aversion | 1.555061e-2 |
GO:0014819 | regulation of skeletal muscle contraction | 1.558343e-2 |
GO:0071354 | cellular response to interleukin-6 | 1.583549e-2 |
GO:0060033 | anatomical structure regression | 1.595945e-2 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.596079e-2 |
GO:0032364 | oxygen homeostasis | 1.605003e-2 |
GO:0021756 | striatum development | 1.606698e-2 |
GO:0046847 | filopodium assembly | 1.611192e-2 |
GO:0043586 | tongue development | 1.617860e-2 |
GO:0045768 | positive regulation of anti-apoptosis | 1.622998e-2 |
GO:0016539 | intein-mediated protein splicing | 1.625685e-2 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 1.653269e-2 |
GO:0006166 | purine ribonucleoside salvage | 1.653269e-2 |
GO:0006072 | glycerol-3-phosphate metabolic process | 1.665566e-2 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 1.666108e-2 |
GO:0021915 | neural tube development | 1.670771e-2 |
GO:0050918 | positive chemotaxis | 1.681143e-2 |
GO:0000724 | double-strand break repair via homologous recombination | 1.681143e-2 |
GO:0070831 | basement membrane assembly | 1.698072e-2 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 1.698072e-2 |
GO:0046500 | S-adenosylmethionine metabolic process | 1.699811e-2 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.699873e-2 |
GO:0014743 | regulation of muscle hypertrophy | 1.707384e-2 |
GO:0003283 | atrial septum development | 1.707384e-2 |
GO:0045123 | cellular extravasation | 1.709617e-2 |
GO:0035990 | tendon cell differentiation | 1.722454e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.722454e-2 |
GO:0045862 | positive regulation of proteolysis | 1.725317e-2 |
GO:0051297 | centrosome organization | 1.747684e-2 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 1.755879e-2 |
GO:0043409 | negative regulation of MAPKKK cascade | 1.762763e-2 |
GO:0006661 | phosphatidylinositol biosynthetic process | 1.809097e-2 |
GO:0072166 | posterior mesonephric tubule development | 1.817391e-2 |
GO:0019344 | cysteine biosynthetic process | 1.817391e-2 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 1.841063e-2 |
GO:0050765 | negative regulation of phagocytosis | 1.896164e-2 |
GO:2000020 | positive regulation of male gonad development | 1.904222e-2 |
GO:0033373 | maintenance of protease location in mast cell secretory granule | 1.916135e-2 |
GO:0033382 | maintenance of granzyme B location in T cell secretory granule | 1.916135e-2 |
GO:0032225 | regulation of synaptic transmission, dopaminergic | 1.937955e-2 |
GO:0032486 | Rap protein signal transduction | 1.940419e-2 |
GO:0052572 | response to host immune response | 1.950360e-2 |
GO:0060413 | atrial septum morphogenesis | 2.020291e-2 |
GO:0030834 | regulation of actin filament depolymerization | 2.032841e-2 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 2.037134e-2 |
GO:0007049 | cell cycle | 2.047905e-2 |
GO:0001843 | neural tube closure | 2.087273e-2 |
GO:0021559 | trigeminal nerve development | 2.109454e-2 |
GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 2.126749e-2 |
GO:0030327 | prenylated protein catabolic process | 2.126749e-2 |
GO:0008295 | spermidine biosynthetic process | 2.126749e-2 |
GO:0014063 | negative regulation of serotonin secretion | 2.126749e-2 |
GO:0030035 | microspike assembly | 2.128316e-2 |
GO:0045637 | regulation of myeloid cell differentiation | 2.140424e-2 |
GO:0030433 | ER-associated protein catabolic process | 2.157825e-2 |
GO:0048742 | regulation of skeletal muscle fiber development | 2.166303e-2 |
GO:0010811 | positive regulation of cell-substrate adhesion | 2.168476e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 2.168854e-2 |
GO:0032481 | positive regulation of type I interferon production | 2.170444e-2 |
GO:0032677 | regulation of interleukin-8 production | 2.172550e-2 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 2.181828e-2 |
GO:0010832 | negative regulation of myotube differentiation | 2.181828e-2 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.185664e-2 |
GO:0031055 | chromatin remodeling at centromere | 2.206946e-2 |
GO:0003151 | outflow tract morphogenesis | 2.214765e-2 |
GO:0006412 | translation | 2.216217e-2 |
GO:0043103 | hypoxanthine salvage | 2.224515e-2 |
GO:0060540 | diaphragm morphogenesis | 2.224515e-2 |
GO:0060464 | lung lobe formation | 2.224515e-2 |
GO:0032261 | purine nucleotide salvage | 2.224515e-2 |
GO:0018065 | protein-cofactor linkage | 2.224515e-2 |
GO:0006168 | adenine salvage | 2.224515e-2 |
GO:0031648 | protein destabilization | 2.243352e-2 |
GO:0051584 | regulation of dopamine uptake | 2.247382e-2 |
GO:0043101 | purine-containing compound salvage | 2.247382e-2 |
GO:0010830 | regulation of myotube differentiation | 2.266381e-2 |
GO:0035993 | deltoid tuberosity development | 2.278589e-2 |
GO:0016075 | rRNA catabolic process | 2.278589e-2 |
GO:0010572 | positive regulation of platelet activation | 2.278589e-2 |
GO:0060562 | epithelial tube morphogenesis | 2.300665e-2 |
GO:0007019 | microtubule depolymerization | 2.308518e-2 |
GO:0003278 | apoptosis involved in heart morphogenesis | 2.308518e-2 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 2.314243e-2 |
GO:0048588 | developmental cell growth | 2.316251e-2 |
GO:0061004 | pattern specification involved in kidney development | 2.340536e-2 |
GO:0051891 | positive regulation of cardioblast differentiation | 2.360157e-2 |
GO:0043587 | tongue morphogenesis | 2.360157e-2 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 2.373874e-2 |
GO:0071284 | cellular response to lead ion | 2.373874e-2 |
GO:0060096 | serotonin secretion, neurotransmission | 2.373874e-2 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 2.373874e-2 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 2.373874e-2 |
GO:0006571 | tyrosine biosynthetic process | 2.373874e-2 |
GO:0021545 | cranial nerve development | 2.376976e-2 |
GO:0018027 | peptidyl-lysine dimethylation | 2.381592e-2 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 2.381592e-2 |
GO:0030853 | negative regulation of granulocyte differentiation | 2.411539e-2 |
GO:0003382 | epithelial cell morphogenesis | 2.426062e-2 |
GO:0060986 | endocrine hormone secretion | 2.435292e-2 |
GO:0019695 | choline metabolic process | 2.466306e-2 |
GO:0009083 | branched chain family amino acid catabolic process | 2.466306e-2 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 2.492607e-2 |
GO:0031054 | pre-miRNA processing | 2.504679e-2 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 2.504679e-2 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.507001e-2 |
GO:0000725 | recombinational repair | 2.517961e-2 |
GO:0071526 | semaphorin-plexin signaling pathway | 2.535516e-2 |
GO:0043088 | regulation of Cdc42 GTPase activity | 2.563424e-2 |
GO:0043486 | histone exchange | 2.588374e-2 |
GO:0008595 | anterior/posterior axis specification, embryo | 2.595052e-2 |
GO:0035050 | embryonic heart tube development | 2.629498e-2 |
GO:0035162 | embryonic hemopoiesis | 2.649128e-2 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 2.651825e-2 |
GO:0072284 | metanephric S-shaped body morphogenesis | 2.651825e-2 |
GO:0055099 | response to high density lipoprotein particle stimulus | 2.651825e-2 |
GO:0035022 | positive regulation of Rac protein signal transduction | 2.658495e-2 |
GO:0006596 | polyamine biosynthetic process | 2.658495e-2 |
GO:0070542 | response to fatty acid | 2.663489e-2 |
GO:0071223 | cellular response to lipoteichoic acid | 2.675717e-2 |
GO:0070925 | organelle assembly | 2.675967e-2 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 2.687455e-2 |
GO:0042255 | ribosome assembly | 2.740572e-2 |
GO:0000188 | inactivation of MAPK activity | 2.746749e-2 |
GO:0010810 | regulation of cell-substrate adhesion | 2.781294e-2 |
GO:0042659 | regulation of cell fate specification | 2.814109e-2 |
GO:0021516 | dorsal spinal cord development | 2.814109e-2 |
GO:0046487 | glyoxylate metabolic process | 2.816371e-2 |
GO:0042245 | RNA repair | 2.816371e-2 |
GO:0008306 | associative learning | 2.816491e-2 |
GO:0021549 | cerebellum development | 2.837237e-2 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 2.853217e-2 |
GO:0060606 | tube closure | 2.899657e-2 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 2.931398e-2 |
GO:0045109 | intermediate filament organization | 2.951452e-2 |
GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 2.962140e-2 |
GO:0045815 | positive regulation of gene expression, epigenetic | 2.962140e-2 |
GO:0009948 | anterior/posterior axis specification | 2.970388e-2 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.978291e-2 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 2.990207e-2 |